Then, Endo et al constructed a model using TBS, AFP, neutrophil-lymphocyte ratio, albumin, gamma-glutamyl transpeptides and vascular involvement, and found that the model was more effective than BCLC in predicting 5-year OS in HCC patients [33]. This evidence concerns the gene ALB and hepatocellular carcinoma.